Jim Cramer’s Thoughts on These 5 Stocks

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 92

A caller asked about Pfizer Inc. (NYSE:PFE), and in reply, Cramer said:

“You know, this is a quandary. And I’ll tell you what, Dr. Bourla, terrific guy, he bought Seagen, I think it’s going to be great. Right now, it’s caught in a vortex where they can’t seem to be able to produce things to offset things that are coming off patent. I want to stick with it, but that 7.7% yield is not a sign of strength. It’s now a sign of weakness.”

Pfizer (NYSE:PFE) is engaged in researching, developing, producing, and distributing biopharmaceutical drugs. The company is involved in treatments for heart disease, infectious diseases, cancer, immune disorders, and vaccines. Two weeks ago, discussing the company, Cramer stated:

“Well, let me tell you something… right now, we have a government that is trying to figure out whether it’s going to tax the heck out of drug companies, raise tariffs outta drug companies or not. I can’t make a prediction anymore. It yields 8%. Normally I say fine, but you know what? Let’s say you decide, you know what, we need big tariffs on Pfizer. You’ll say, wow, I’m buying that stock at 18 rather than 21. So I’m going to have to say, pass.”

While we acknowledge the potential of Pfizer Inc. (NYSE:PFE) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.